Publications
Detailed Information
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gennari, A. | - |
dc.contributor.author | Andre, F. | - |
dc.contributor.author | Barrios, C. H. | - |
dc.contributor.author | Cortes, J. | - |
dc.contributor.author | de Azambuja, E. | - |
dc.contributor.author | DeMichele, A. | - |
dc.contributor.author | Dent, R. | - |
dc.contributor.author | Fenlon, D. | - |
dc.contributor.author | Gligorov, J. | - |
dc.contributor.author | Hurvitz, S. A. | - |
dc.contributor.author | Im, S. -a. | - |
dc.contributor.author | Krug, D. | - |
dc.contributor.author | Kunz, W. G. | - |
dc.contributor.author | Loi, S. | - |
dc.contributor.author | Penault-Llorca, F. | - |
dc.contributor.author | Ricke, J. | - |
dc.contributor.author | Robson, M. | - |
dc.contributor.author | Rugo, H. S. | - |
dc.contributor.author | Saura, C. | - |
dc.contributor.author | Schmid, P. | - |
dc.contributor.author | Singer, C. F. | - |
dc.contributor.author | Spanic, T. | - |
dc.contributor.author | Tolaney, S. M. | - |
dc.contributor.author | Turner, N. C. | - |
dc.contributor.author | Curigliano, G. | - |
dc.contributor.author | Loibl, S. | - |
dc.contributor.author | Paluch-Shimon, S. | - |
dc.contributor.author | Harbeck, N. | - |
dc.contributor.author | ESMO Guidelines Committee | - |
dc.date.accessioned | 2022-04-26T07:12:31Z | - |
dc.date.available | 2022-04-26T07:12:31Z | - |
dc.date.created | 2022-01-07 | - |
dc.date.created | 2022-01-07 | - |
dc.date.created | 2022-01-07 | - |
dc.date.issued | 2021-12 | - |
dc.identifier.citation | Annals of Oncology, Vol.32 No.12, pp.1475-1495 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.other | 153495 | - |
dc.identifier.uri | https://hdl.handle.net/10371/179242 | - |
dc.language | 영어 | - |
dc.publisher | Oxford University Press | - |
dc.title | ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer | - |
dc.type | Article | - |
dc.contributor.AlternativeAuthor | 임석아 | - |
dc.identifier.doi | 10.1016/j.annonc.2021.09.019 | - |
dc.citation.journaltitle | Annals of Oncology | - |
dc.identifier.wosid | 000721610600008 | - |
dc.identifier.scopusid | 2-s2.0-85120812833 | - |
dc.citation.endpage | 1495 | - |
dc.citation.number | 12 | - |
dc.citation.startpage | 1475 | - |
dc.citation.volume | 32 | - |
dc.identifier.sci | 000721610600008 | - |
dc.description.isOpenAccess | Y | - |
dc.contributor.affiliatedAuthor | Im, S. -a. | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | INTERNATIONAL CONSENSUS GUIDELINES | - |
dc.subject.keywordPlus | ALPELISIB PLUS FULVESTRANT | - |
dc.subject.keywordPlus | GERMLINE BRCA MUTATION | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | OPEN-LABEL | - |
dc.subject.keywordPlus | PHYSICIANS CHOICE | - |
dc.subject.keywordPlus | SACITUZUMAB GOVITECAN | - |
dc.subject.keywordPlus | TRASTUZUMAB EMTANSINE | - |
dc.subject.keywordPlus | REPORTED OUTCOMES | - |
dc.subject.keywordPlus | ENDOCRINE THERAPY | - |
dc.subject.keywordAuthor | diagnosis | - |
dc.subject.keywordAuthor | ESCAT | - |
dc.subject.keywordAuthor | ESMO Clinical Practice Guideline | - |
dc.subject.keywordAuthor | ESMO-MCBS | - |
dc.subject.keywordAuthor | metastatic breast cancer | - |
dc.subject.keywordAuthor | treatment | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.